Riccardo Soffietti

Dec 9, 2024 | nature.com | Ahmad Ozair |Nicholas Mikolajewicz |Stuart A Grossman |Arjun Sahgal |Emilie Le Rhun |Michael Weller | +12 more

AbstractLeptomeningeal metastatic disease (LMD), encompassing entities of ‘meningeal carcinomatosis’, neoplastic meningitis’ and ‘leukaemic/lymphomatous meningitis’, arises secondary to the metastatic dissemination of cancer cells from extracranial and certain intracranial malignancies into the leptomeninges and cerebrospinal fluid.

Sep 1, 2023 | medscape.com | Mehdi Touat |Riccardo Soffietti

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. There has long been a challenge in the clinical management of diffuse IDH-mutant glioma with no curative therapies and very few treatment options for most patients.

Jun 26, 2023 | mdpi.com | Riccardo Soffietti |Alessia Pellerino |Francesco Bruno |Alessandro Mauro

1. IntroductionImprovements in technology have allowed, in recent years, the delivery of more conformal doses of radiation to primary brain tumors in adults, for instance gliomas, thus minimizing the risk of late adverse effects in the normal brain. However, brain metastases or primary central nervous system lymphomas (PCNSL), due to their multiplicity, cannot profit from these conformal advances, and still need treatments covering a major part of the brain.

Jun 9, 2023 | onlinelibrary.wiley.com | Riccardo Soffietti |David B. Vodušek |European Academy |Benedikt Schoser

European Training Requirements for Neurology (ETRN) In 2021 the President of the EAN (CB) and four members of the EAN board (CB, RS, DV, PB) started an in-depth revision of the ETRN 2016 version motivated by several considerations. First, knowledge in basic and clinical neurosciences is increasing exponentially. Secondly, the subspecialization in neurology is increasing. For example, in 2012 there were 25 neurological subspecialties recognized in the United States [22].

Jun 5, 2023 | medscape.com | Riccardo Soffietti |Mehdi Touat

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log outCancel There has long been a challenge in the clinical management of diffuse IDH-mutant glioma with no curative therapies and very few treatment options for most patients.